Hematological Cancer Treatment at Karolinska University Hospital

Hematological Cancer Treatment provides specialized care for cancers affecting the blood, bone marrow and lymphatic system, including conditions such as leukemia, lymphoma and multiple myeloma. Treatment may involve chemotherapy, targeted therapy, immunotherapy, stem cell transplantation and other specialized hematology-oncology approaches, depending on the diagnosis.

Price

Price on Request

Why Price on Request?

The cost varies according to the type and stage of hematological cancer, diagnostic investigations, treatment protocol, medications, hospitalization, transplantation requirements and follow-up care. A personalized cost estimate can be provided after specialist assessment.

Complete Description

What Is Hematological Cancer Treatment?

Hematological cancer treatment focuses on cancers affecting the blood-forming tissues, bone marrow and lymphatic system.

It may include treatment for:

• Leukemia

• Lymphoma

• Multiple myeloma

• Other blood and bone-marrow cancers

The treatment approach depends on the specific diagnosis and individual patient factors.

Who May Need Hematological Cancer Treatment?

Specialist treatment may be considered for patients with:

• Newly diagnosed blood cancer

• Relapsed hematological cancer

• Advanced disease

• Abnormal blood-cell findings requiring specialist assessment

• Bone-marrow disorders associated with cancer

• Lymphatic malignancies

Hematology-Oncology Evaluation

Assessment may include:

• Medical history

• Physical examination

• Blood tests

• Bone-marrow evaluation

• Imaging

• Pathology

• Molecular or genetic testing when appropriate

These investigations help establish an accurate diagnosis and treatment plan.

Leukemia Treatment

Leukemia treatment depends on the specific type and characteristics of the disease.

Treatment may involve:

• Chemotherapy

• Targeted therapy

• Immunotherapy

• Stem cell transplantation

• Supportive care

The treatment plan is individualized according to the leukemia subtype and patient's condition.

Lymphoma Treatment

Lymphoma treatment depends on the type, stage and biological characteristics of the lymphoma.

Potential approaches may include:

• Chemotherapy

• Immunotherapy

• Targeted therapy

• Radiation therapy

• Stem cell transplantation in selected cases

Multiple Myeloma Treatment

Multiple myeloma treatment may involve combinations of systemic medicines designed to control abnormal plasma cells.

Depending on the patient's condition, treatment may include:

• Targeted medicines

• Immunotherapy

• Chemotherapy

• Stem cell transplantation

• Supportive treatment

Bone Marrow Assessment

Bone marrow examination may be used to:

• Confirm a diagnosis

• Determine disease characteristics

• Assess treatment response

• Monitor disease progression

The need for bone marrow testing depends on the suspected or confirmed condition.

Molecular and Genetic Testing

Selected hematological cancers may require molecular or genetic testing to identify important disease characteristics.

Results can assist specialists in:

• Confirming disease subtype

• Assessing prognosis

• Selecting targeted treatment

• Monitoring disease

Chemotherapy

Chemotherapy uses medicines to destroy or control abnormal cancer cells.

Treatment schedules vary according to:

• Cancer type

• Disease stage

• Treatment protocol

• Patient response

Targeted Therapy

Targeted treatments are designed to act on specific molecular or biological characteristics of cancer cells.

They may be used when appropriate molecular features are identified.

Immunotherapy

Immunotherapy uses the patient's immune system to help recognize and attack cancer cells.

It may be considered for selected hematological cancers depending on the diagnosis.

Stem Cell Transplantation

For selected patients, stem cell transplantation may form part of treatment.

The suitability of transplantation depends on:

• Cancer type

• Disease status

• Previous treatment

• Overall health

• Donor availability when required

Supportive Cancer Care

Hematological cancer treatment may require supportive care to manage complications and treatment effects.

This may include monitoring and management of:

• Blood counts

• Infections

• Anemia

• Bleeding risk

• Treatment-related symptoms

• Nutritional needs

Treatment Response Monitoring

Specialists may monitor:

• Blood counts

• Bone marrow findings

• Imaging

• Molecular markers

• Disease symptoms

• Treatment-related effects

Testing frequency depends on the specific cancer and treatment plan.

Relapsed or Refractory Hematological Cancer

Patients whose cancer has returned or does not respond adequately to initial treatment may require further specialist assessment.

Treatment options depend on:

• Cancer type

• Previous treatment

• Disease characteristics

• Treatment response

• Overall health

Multidisciplinary Hematological Cancer Care

Complex cases may involve collaboration between:

• Hematologists

• Medical oncologists

• Pathologists

• Radiologists

• Transplant specialists

• Laboratory specialists

• Other healthcare professionals

Hematological Cancer Second Opinion

Patients may seek a specialist second opinion regarding:

• Blood cancer diagnosis

• Pathology

• Bone marrow results

• Treatment recommendations

• Chemotherapy

• Targeted therapy

• Immunotherapy

• Stem cell transplantation

Relevant medical records can be reviewed by specialists.

International Patient Hematological Cancer Treatment

International patients seeking hematological cancer treatment in Sweden should provide relevant medical documentation whenever available.

Useful records may include:

• Blood test results

• Bone marrow reports

• Pathology reports

• Molecular or genetic testing

• CT or PET scans

• Previous oncology reports

• Treatment history

• Medication list

Complete records can help specialists assess the condition and determine an appropriate treatment pathway.

Benefits of Specialized Hematological Cancer Care

Specialized care may help:

• Diagnose complex blood cancers

• Develop individualized treatment plans

• Provide systemic cancer treatment

• Evaluate stem cell transplantation

• Monitor treatment response

• Manage treatment complications

• Assess relapsed or refractory disease

• Provide specialist second opinions

• Coordinate multidisciplinary care

Why Choose Karolinska University Hospital for Hematological Cancer Treatment?

Karolinska University Hospital is a major university hospital in Sweden providing specialized hematology, oncology, laboratory and multidisciplinary medical services.

Patients with complex hematological cancers may be assessed through relevant specialist services according to their diagnosis, medical needs and eligibility.

The specific treatment pathway depends on specialist assessment.

Cost & Price on Request

Price: Price on Request

The total cost depends on the cancer diagnosis and treatment requirements.

Potential costs may include:

• Hematology consultation

• Blood testing

• Bone marrow examination

• Imaging

• Pathology

• Molecular testing

• Chemotherapy

• Targeted therapy

• Immunotherapy

• Stem cell transplantation

• Hospitalization

• Follow-up care

A personalized cost estimate can be requested following specialist assessment.

Frequently Asked Questions

1. Which cancers are considered hematological cancers?

Hematological cancers include diseases such as leukemia, lymphoma and multiple myeloma that affect blood-forming tissues, bone marrow or the lymphatic system.

2. Does every blood cancer require chemotherapy?

No. Treatment depends on the specific cancer and may include targeted therapy, immunotherapy, transplantation or other approaches.

3. What is stem cell transplantation?

Stem cell transplantation is a specialized treatment that may be used for selected hematological cancers and involves replacing or restoring blood-forming stem cells.

4. Can I get a blood cancer second opinion in Sweden?

Patients may request specialist review of their diagnosis, pathology, bone marrow results and treatment plan, subject to applicable hospital requirements.

5. Can international patients receive hematological cancer treatment in Sweden?

International patients may request specialist assessment and treatment subject to applicable hospital processes, medical requirements, eligibility and program availability.

Product Details

Product Name: Hematological Cancer Treatment

Hospital: Karolinska University Hospital

Brand: Karolinska University Hospital

Country: Sweden

Specialty: Oncology & Cancer Care

Service Type: Hematological Cancer Treatment

Customer-Facing Price: Price on Request

International Patients: Subject to applicable eligibility and program requirements

Location: Stockholm, Sweden